Underlying genetic variation in familial frontotemporal dementia: sequencing of 198 patients.
Cell Cycle Proteins
/ genetics
Cytoskeletal Proteins
/ genetics
DNA-Binding Proteins
/ genetics
Female
Frontotemporal Dementia
/ genetics
Genetic Association Studies
Genetic Predisposition to Disease
/ genetics
Genetic Variation
/ genetics
Humans
Male
Membrane Transport Proteins
/ genetics
Presenilin-1
/ genetics
Protein Serine-Threonine Kinases
/ genetics
Valosin Containing Protein
/ genetics
Exome Sequencing
tau Proteins
/ genetics
Familial
Frontotemporal dementia
Genetic screen
Whole-exome sequencing
Journal
Neurobiology of aging
ISSN: 1558-1497
Titre abrégé: Neurobiol Aging
Pays: United States
ID NLM: 8100437
Informations de publication
Date de publication:
01 2021
01 2021
Historique:
received:
17
04
2020
revised:
01
06
2020
accepted:
14
07
2020
pubmed:
28
8
2020
medline:
2
9
2021
entrez:
27
8
2020
Statut:
ppublish
Résumé
Frontotemporal dementia (FTD) presents with a wide variability in clinical syndromes, genetic etiologies, and underlying pathologies. Despite the discovery of pathogenic variants in several genes, many familial cases remain unsolved. In a large FTD cohort of 198 familial patients, we aimed to determine the types and frequencies of variants in genes related to FTD. Pathogenic or likely pathogenic variants were revealed in 74 (37%) patients, including 4 novel variants. The repeat expansion in C9orf72 was most common (21%), followed by variants in MAPT (6%), GRN (4.5%), and TARDBP (3.5%). Other pathogenic variants were found in VCP, TBK1, PSEN1, and a novel homozygous variant in OPTN. Furthermore, we identified 15 variants of uncertain significance, including a promising variant in TUBA4A and a frameshift in VCP, for which additional research is needed to confirm pathogenicity. The patients without identified genetic cause demonstrated a wide clinical and pathological variety. Our study contributes to the clinical characterization of the genetic subtypes and confirms the value of whole-exome sequencing in identifying novel genetic variants.
Identifiants
pubmed: 32843152
pii: S0197-4580(20)30230-X
doi: 10.1016/j.neurobiolaging.2020.07.014
pii:
doi:
Substances chimiques
Cell Cycle Proteins
0
Cytoskeletal Proteins
0
DNA-Binding Proteins
0
DNMBP protein, human
0
MAPT protein, human
0
Membrane Transport Proteins
0
OPTN protein, human
0
PSEN1 protein, human
0
Presenilin-1
0
TARDBP protein, human
0
tau Proteins
0
Protein Serine-Threonine Kinases
EC 2.7.11.1
TBK1 protein, human
EC 2.7.11.1
VCP protein, human
EC 3.6.4.6
Valosin Containing Protein
EC 3.6.4.6
Types de publication
Journal Article
Research Support, Non-U.S. Gov't
Langues
eng
Sous-ensembles de citation
IM
Pagination
148.e9-148.e16Informations de copyright
Copyright © 2020 The Author(s). Published by Elsevier Inc. All rights reserved.